Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) – Scarcity of drugs in the pipeline

Adenosine deaminase (ADA) deficiency is an ultra-rare inherited disorder that damages the immune system and causes severe combined immunodeficiency (SCID). It is the second most prevalent form of SCID comprising of almost 15% – 20% of all SCID cases. It is characterized by profound immune deficiency condition resulting in a weak immune system that is unable to fight off even mild infections. Affected infants often …

Read More

Cytomegalovirus (CMV) Infection- More novel therapies required

Cytomegalovirus (CMV) Infection, caused by a common virus in the same family as herpes virus, and it can infect people of all ages. CMV also includes the herpes simplex viruses and the viruses that cause chickenpox and mononucleosis (mono). According to the estimations over half of all adults have been infected with CMV during their lifetime. Researchers are aggressively working to bring new prophylaxis as …

Read More

Spinal Muscular Atrophy – Global market size will increase 2 folds by 2025

Spinal Muscular Atrophy (SMA) is a neuromuscular disorder caused by Bi-allelic mutation of survival motor neuron gene 1 (SMN1). In healthy people this gene produces a protein required by the muscle controlling nerves. In the deficiency of this protein these nerve cells cannot function properly which leads to fatal muscle weakness. It is one of the most common causes of infant death and mobility impairment. …

Read More

Amyotrophic Lateral Sclerosis- Market will see growth of 45% from 2015-2025

Amyotrophic Lateral Sclerosis (ALS) is also known as Lou Gehrig’s disease. It is a progressive, rarely occurring neurological disease that mainly involves the nerve cells (neurons) which are responsible for controlling voluntary muscle movements. With time, it leads to muscle weakness, gradually affecting the functions of the body. Voluntary muscles produce movements like chewing, breathing, talking, and walking. ALS greatly reduces an individual’s life expectancy …

Read More

PARP INHIBITORS- Back to Back drug approval boosting the market

Product pipeline of PARP is highly active with more than 30% of the products in Phase III as per the latest report of DelveInsight. Poly (ADP-ribose) polymerase has emerged as a promising anti-cancer target in the past decade. PARPs are activated by DNA damage and plays an essential role in the repair of DNA Evidences have shown that tumor cells subjected to radio- or chemotherapy …

Read More

Sickle Cell Disease – About to enter into a new Treatment Era

    In 2016 the total number of prevalent population of Sickle Cell Disease (SCD) was found to be more than 130,000 in 6MM, prevalence of this disease is very rare in Japan. Sickle cell disease, also known as sickle cell anemia, is a group of disorders affecting the red blood cells in the body. Currently, there is still no cure for the sickle cell …

Read More
8th Annual New Media Film Festival

The top 21 New Media Films and Content for 2017 includes Web Series, TV and Episodic

  (Los Angeles, CA) – There were new learning experiences for everyone at the 8th New Media Film Festival which has always been on the cutting edge of film making and this year did not disappoint. Susan Johnston, Founder/Director, New Media Film Festival always makes sure that Film Fest impresses international audiences with its diverse genres and cutting edge methods of storytelling – from web series, …

Read More